Schedule 13G ownership disclosure

PHARVARIS N V

Ordinary Shares, Euro 0.12 par value per share · CUSIP: N69605108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Bain Capital Life Sciences Fund, L.P.

    Shares: 1,867,629 · Class: 3.0%

  • BCIP Life Sciences Associates, LP

    Shares: 191,165 · Class: 0.3%

  • Bain Capital Life Sciences Opportunities III, LP

    Shares: 1,122,481 · Class: 1.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-283110
Form type
SCHEDULE 13G/A
Filer
Bain Capital Life Sciences Fund, L.P.
CIK
CIK 1687968
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub